Sabra Health Care REIT
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
29.6027.80N/AN/A
Price/Sales ratio
6.226.095.184.90
Earnings per Share (EPS)
$0.64$0.68N/AN/A

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
29.9815.8522.6812.5110.5257.8925.87-26.19-36.99239.8441.0310.52
Price/Sales ratio
7.675.276.114.884.716.035.985.204.595.095.804.71
Price/Book Value ratio
1.491.191.560.570.901.141.050.870.931.171.450.90
Price/Cash Flow ratio
16.4910.399.0214.858.1910.7210.098.329.0910.9712.898.19
Price/Free Cash Flow ratio
16.4910.399.02-9.886.5010.7214.379.189.0910.9712.806.50
Price/Earnings Growth ratio
2.060.39-1.320.230.86-0.750.310.141.06-2.04-13.54-0.75
Dividend Yield
5.78%8.72%7.48%9.18%11.06%8.39%7.76%8.86%9.65%8.40%7.05%8.39%
Profitability Indicator Ratios
Gross Profit Margin
97.86%98.92%97.81%95.59%92.05%83.60%78.02%75.20%73.97%41.57%51.72%83.60%
Operating Profit Margin
60.40%57.14%61.75%55.31%49.23%50.67%40.30%3.34%21.69%34.21%38.19%50.67%
Pretax Profit Margin
25.56%33.23%26.94%39.20%45.25%10.94%23.24%-19.56%-12.22%2.43%14.18%14.18%
Net Profit Margin
25.58%33.24%26.97%39.04%44.76%10.42%23.12%-19.88%-12.42%2.12%14.01%14.01%
Effective Tax Rate
103.33%77.40%107.51%0.40%1.06%4.69%0.51%-1.65%-1.62%12.70%1.13%1.06%
Return on Assets
2.27%3.19%3.10%2.25%4.18%1.13%2.31%-1.89%-1.35%0.25%1.81%1.81%
Return On Equity
4.98%7.53%6.91%4.61%8.58%1.97%4.06%-3.35%-2.53%0.49%3.50%3.50%
Return on Capital Employed
5.45%5.56%7.22%3.23%4.67%5.62%4.13%0.32%2.41%4.29%7.34%4.67%
Liquidity Ratios
Current Ratio
12.6711.845.318.023.122.411.94N/AN/AN/A0.102.41
Quick Ratio
13.1812.696.458.493.592.271.753.721.410.910.102.27
Cash ratio
1.940.210.645.050.520.350.400.780.340.170.030.35
Days of Sales Outstanding
467.74412.85N/A211.26138.53117.76133.87307.7086.4058.2263.96117.76
Days of Inventory outstanding
N/AN/AN/AN/AN/A199.16199.68309.61923.41N/AN/A199.16
Operating Cycle
467.74412.85N/A211.26138.53316.93333.55617.321.00K58.2263.96316.93
Days of Payables Outstanding
2.96K4.98K2.53K2.09K698.58253.60200.20369.62319.3171.19N/A253.60
Cash Conversion Cycle
-2.49K-4.57K-2.53K-1.88K-560.0463.33133.35247.69690.50-12.9663.96-560.04
Debt Ratios
Debt Ratio
0.520.560.530.480.480.390.390.400.470.440.460.46
Debt Equity Ratio
1.151.321.190.980.990.680.690.700.880.860.890.89
Long-term Debt to Capitalization
0.530.570.540.490.490.400.400.410.450.450.470.47
Total Debt to Capitalization
0.530.570.540.490.490.400.410.410.460.460.470.47
Interest Coverage Ratio
2.362.302.482.532.082.682.54N/AN/AN/A2.022.68
Cash Flow to Debt Ratio
0.070.080.140.030.110.150.140.140.110.120.120.11
Company Equity Multiplier
2.192.352.232.042.051.731.751.761.881.921.951.95
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.460.500.670.320.570.560.590.620.500.460.440.56
Free Cash Flow / Operating Cash Flow Ratio
111-1.501.2610.700.90111.011.01
Cash Flow Coverage Ratio
0.070.080.140.030.110.150.140.140.110.120.120.11
Short Term Coverage Ratio
N/AN/A42.81N/A104.80104.3919.2620.381.603.11N/A104.39
Dividend Payout Ratio
173.55%138.38%169.70%114.96%116.53%486.16%201.05%-232.14%-357.13%2016.91%286.64%116.53%